223 related articles for article (PubMed ID: 34523242)
1. A novel mechanism of imeglimin-mediated insulin secretion via the cADPR-TRP channel pathway.
Funazaki S; Yoshida M; Yamada H; Kakei M; Kawakami M; Nagashima S; Hara K; Dezaki K
J Diabetes Investig; 2022 Jan; 13(1):34-41. PubMed ID: 34523242
[TBL] [Abstract][Full Text] [Related]
2. Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.
Hallakou-Bozec S; Kergoat M; Fouqueray P; Bolze S; Moller DE
PLoS One; 2021; 16(2):e0241651. PubMed ID: 33606677
[TBL] [Abstract][Full Text] [Related]
3. Endogenous α2A-Adrenoceptor-Operated Sympathoadrenergic Tones Attenuate Insulin Secretion via cAMP/TRPM2 Signaling.
Ito K; Dezaki K; Yoshida M; Yamada H; Miura R; Rita RS; Ookawara S; Tabei K; Kawakami M; Hara K; Morishita Y; Yada T; Kakei M
Diabetes; 2017 Mar; 66(3):699-709. PubMed ID: 28028077
[TBL] [Abstract][Full Text] [Related]
4. Redox Signal-mediated Enhancement of the Temperature Sensitivity of Transient Receptor Potential Melastatin 2 (TRPM2) Elevates Glucose-induced Insulin Secretion from Pancreatic Islets.
Kashio M; Tominaga M
J Biol Chem; 2015 May; 290(19):12435-42. PubMed ID: 25817999
[TBL] [Abstract][Full Text] [Related]
5. TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion.
Togashi K; Hara Y; Tominaga T; Higashi T; Konishi Y; Mori Y; Tominaga M
EMBO J; 2006 May; 25(9):1804-15. PubMed ID: 16601673
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes.
Hallakou-Bozec S; Vial G; Kergoat M; Fouqueray P; Bolze S; Borel AL; Fontaine E; Moller DE
Diabetes Obes Metab; 2021 Mar; 23(3):664-673. PubMed ID: 33269554
[TBL] [Abstract][Full Text] [Related]
7. Lack of TRPM2 impaired insulin secretion and glucose metabolisms in mice.
Uchida K; Dezaki K; Damdindorj B; Inada H; Shiuchi T; Mori Y; Yada T; Minokoshi Y; Tominaga M
Diabetes; 2011 Jan; 60(1):119-26. PubMed ID: 20921208
[TBL] [Abstract][Full Text] [Related]
8. Direct Gating of the TRPM2 Channel by cADPR via Specific Interactions with the ADPR Binding Pocket.
Yu P; Liu Z; Yu X; Ye P; Liu H; Xue X; Yang L; Li Z; Wu Y; Fang C; Zhao YJ; Yang F; Luo JH; Jiang LH; Zhang L; Zhang L; Yang W
Cell Rep; 2019 Jun; 27(12):3684-3695.e4. PubMed ID: 31216484
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effect of imeglimin on incretin secretion.
Yingyue Q; Sugawara K; Takahashi H; Yokoi N; Ohbayashi K; Iwasaki Y; Seino S; Ogawa W
J Diabetes Investig; 2023 Jun; 14(6):746-755. PubMed ID: 36977210
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential melastatin-2 and temperature participate in the process of CD38-regulated oxytocin secretion.
Liu HX; Ma S; Nan Y; Yang WH
Neuroreport; 2016 Aug; 27(12):935-9. PubMed ID: 27348016
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cAMP/EPAC/TRPM2 activation in glucose- and incretin-induced insulin secretion.
Yosida M; Dezaki K; Uchida K; Kodera S; Lam NV; Ito K; Rita RS; Yamada H; Shimomura K; Ishikawa SE; Sugawara H; Kawakami M; Tominaga M; Yada T; Kakei M
Diabetes; 2014 Oct; 63(10):3394-403. PubMed ID: 24824430
[TBL] [Abstract][Full Text] [Related]
12. Identification of direct and indirect effectors of the transient receptor potential melastatin 2 (TRPM2) cation channel.
Tóth B; Csanády L
J Biol Chem; 2010 Sep; 285(39):30091-102. PubMed ID: 20650899
[TBL] [Abstract][Full Text] [Related]
13. Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic beta cells. Enhanced insulin secretion in CD38-expressing transgenic mice.
Kato I; Takasawa S; Akabane A; Tanaka O; Abe H; Takamura T; Suzuki Y; Nata K; Yonekura H; Yoshimoto T
J Biol Chem; 1995 Dec; 270(50):30045-50. PubMed ID: 8530408
[TBL] [Abstract][Full Text] [Related]
14. 8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist.
Kirchberger T; Moreau C; Wagner GK; Fliegert R; Siebrands CC; Nebel M; Schmid F; Harneit A; Odoardi F; Flügel A; Potter BV; Guse AH
Biochem J; 2009 Jul; 422(1):139-49. PubMed ID: 19492987
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological profile and clinical efficacy of imeglimin hydrochloride (TWYMEEG
Nagamine J
Nihon Yakurigaku Zasshi; 2023; 158(2):193-202. PubMed ID: 36858505
[TBL] [Abstract][Full Text] [Related]
16. Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents.
Perry RJ; Cardone RL; Petersen MC; Zhang D; Fouqueray P; Hallakou-Bozec S; Bolze S; Shulman GI; Petersen KF; Kibbey RG
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E461-70. PubMed ID: 27406738
[TBL] [Abstract][Full Text] [Related]
17. ["The CD38-cyclic ADP-ribose signal system": molecular mechanism and biological significance].
Okamoto H
Nihon Yakurigaku Zasshi; 1999 Sep; 114(3):131-9. PubMed ID: 10553576
[TBL] [Abstract][Full Text] [Related]
18. Cyclic ADP-ribose and inositol 1,4,5-trisphosphate as alternate second messengers for intracellular Ca2+ mobilization in normal and diabetic beta-cells.
Takasawa S; Akiyama T; Nata K; Kuroki M; Tohgo A; Noguchi N; Kobayashi S; Kato I; Katada T; Okamoto H
J Biol Chem; 1998 Jan; 273(5):2497-500. PubMed ID: 9446548
[TBL] [Abstract][Full Text] [Related]
19. Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels.
Kolisek M; Beck A; Fleig A; Penner R
Mol Cell; 2005 Apr; 18(1):61-9. PubMed ID: 15808509
[TBL] [Abstract][Full Text] [Related]
20. 8-Br-cADPR, a TRPM2 ion channel antagonist, inhibits renal ischemia-reperfusion injury.
Eraslan E; Tanyeli A; Polat E; Polat E
J Cell Physiol; 2019 Apr; 234(4):4572-4581. PubMed ID: 30191993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
